Truist Securities Reiterates Buy on SI-BONE, Lowers Price Target to $18

Benzinga Newsdesk www.benzinga.com Negative 78.5%

Neg 78.5% Neu 0% Pos 0%

Truist Securities analyst Richard Newitter reiterates SI-BONE (NASDAQ:SIBN) with a Buy and lowers the price target from $20 to $18.